Long-Term Benefit–Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis

被引：0
|
作者：
April W. Armstrong
Ahmed M. Soliman
Keith A. Betts
Yan Wang
Yawen Gao
Vassilis Stakias
Luis Puig
机构：
[1] University of Southern California,Department of Dermatology, Keck School of Medicine
[2] AbbVie,Department of Dermatology, Hospital de la Santa Creu i Sant Pau
[3] Inc.,undefined
[4] Analysis Group,undefined
[5] Inc.,undefined
[6] AbbVie,undefined
[7] Inc.,undefined
[8] Universitat Autònoma de Barcelona,undefined
来源：
Dermatology and Therapy | 2022年 / 12卷
关键词：
Long-term benefit–risk profile; Risankizumab; Bimekizumab; Ixekizumab; Network meta-analysis; Moderate-to-severe plaque psoriasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：167 / 184
页数：17
相关论文
共 50 条
  • [11] Short term efficacy of biological treatment for moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis
    Ismail, Omar
    Jaber, Kamel
    Jaber, Yazan
    Froukh, Ubadah
    Younis, Ahmad
    Albdour, Karam
    Momani, Yazan
    Almaani, Noor
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (10)
  • [12] Indirect comparison of the short-, mid-, and long-term efficacy of treatments for moderate to severe plaque psoriasis: A systematic review and network meta-analysis
    Penas, Pablo Fernandez
    Armstrong, April W.
    Warren, Richard B.
    Zhong, Yichen
    Zhuo, Joe
    Cichewicz, Allie
    Kadambi, Ananth
    Junqueira, Daniela
    Westley, Tracy
    Kisa, Renata M.
    Daamen, Carolin
    Augustin, Matthias
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 23 - 23
  • [13] INDIRECT COMPARISON OF SHORT-, MID-, AND LONG-TERM EFFICACY OF TREATMENTS FOR MODERATE TO SEVERE PLAQUE PSORIASIS: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS
    Armstrong, A. W.
    Warren, R. B.
    Zhong, Y.
    Zhuo, J.
    Cichewicz, A.
    Kadambi, A.
    Junqueira, D.
    Westley, T.
    Kisa, R.
    Daamen, C.
    Augustin, M.
    VALUE IN HEALTH, 2022, 25 (12) : S493 - S493
  • [14] Short-term effectiveness of biologics in patients with moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis
    Tada, Yayoi
    Watanabe, Rei
    Noma, Hisashi
    Kanai, Yasumasa
    Nomura, Takanobu
    Kaneko, Kenji
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2020, 99 (01) : 53 - 61
  • [15] Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment
    Lucka, T. C.
    Pathirana, D.
    Sammain, A.
    Bachmann, F.
    Rosumeck, S.
    Erdmann, R.
    Schmitt, J.
    Orawa, H.
    Rzany, B.
    Nast, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (11) : 1331 - 1344
  • [16] Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data
    Shear, Neil H.
    Betts, Keith A.
    Soliman, Ahmed M.
    Joshi, Avani
    Wang, Yan
    Zhao, Jing
    Gisondi, Paolo
    Sinvhal, Ranjeeta
    Armstrong, April W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : 572 - 581
  • [17] Letter to the editor concerning the article: "Comparative safety and benefit-risk profile of biologics and oral treatments for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data"
    Pettitt, Dan
    Plotnick, Michael
    Miller, Lloyd S.
    Berlin, Jesse A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (05) : E305 - E306
  • [18] EFFICACY OF BRODALUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS: A NETWORK META-ANALYSIS
    Xue, W.
    Barbeau, M.
    Khoudigian-Sinani, S.
    Gray, E.
    Saharia, P.
    Frieder, D.
    VALUE IN HEALTH, 2018, 21 : S239 - S239
  • [19] Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
    Zheng, Jianfeng
    Chen, Wenjuan
    Yi, Xuemei
    Yu, Ning
    Ding, Yangfeng
    Gao, Yunlu
    FRONTIERS IN MEDICINE, 2023, 10
  • [20] Network meta-analysis: treatments for plaque psoriasis
    Reactions Weekly, 2021, 1846 (1) : 10 - 10
12345